Valuation
- Market cap
- 33,740,000
- Revenue TTM
- $34,510,000
- Net income TTM
- $-11,140,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -32.28%
- Debt to equity
- 0.13
Trading
- Volume
- 25,300
- Avg volume
- 29,718
- Day's range
- $1.65 – $1.83
- Shares out
- 19,616,000
- Stochastic %K
- 60%
- Beta
- 1.04
- Analysts
- Strong Sell
- Price target
- $10.50
Company profile
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical...
Show more
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.
- Industry
- Packaged Foods
- Sector
- Consumer Defensive
- Phone
- 604 689 5722
- Website
- https://www.bioharvest.com
- Address
- 1140-625 Howe Street, Vancouver, Canada
Latest news
No headlines yet.